Search Results - "Murdock, H. Moses"

Virtual Morning Report during COVID‐19: A novel model for case‐based teaching conferences by Murdock, H. Moses, Penner, John C., Le, Stephenie, Nematollahi, Saman

Get full text

Trends in Racial/Ethnic Representation Among US Medical Students by Lett, Lanair Amaad, Murdock, H Moses, Orji, Whitney U, Aysola, Jaya, Sebro, Ronnie

“…With increasing efforts to create a diverse physician workforce that is reflective of the demographic characteristics of the US population, it remains unclear…”
Get full text

Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation by Gibson, Christopher J, Kim, Haesook T, Zhao, Lin, Murdock, H Moses, Hambley, Bryan, Ogata, Alana, Madero-Marroquin, Rafael, Wang, Shiyu, Green, Lisa, Fleharty, Mark, Dougan, Tyler, Cheng, Chi-An, Blumenstiel, Brendan, Cibulskis, Carrie, Tsuji, Junko, Duran, Madeleine, Gocke, Christopher D, Antin, Joseph H, Nikiforow, Sarah, DeZern, Amy E, Chen, Yi-Bin, Ho, Vincent T, Jones, Richard J, Lennon, Niall J, Walt, David R, Ritz, Jerome, Soiffer, Robert J, Gondek, Lukasz P, Lindsley, R Coleman

“…Clonal hematopoiesis (CH) can be transmitted from a donor to a recipient during allogeneic hematopoietic cell transplantation. Exclusion of candidate donors…”
Get full text

Innovations in conditioning and post-transplant maintenance in AML: genomically informed revelations on the graft-versus-leukemia effect by Murdock, H Moses, Ho, Vincent T, Garcia, Jacqueline S

“…Acute Myeloid Leukemia (AML) is the prototype of cancer genomics as it was the first published cancer genome. Large-scale next generation/massively parallel…”
Get full text

A coach of my own by Murdock, H. Moses, Kogan, Jennifer R.

“…This personal view about medical student self-feedback is based on personal experiences as a third-year medical student with insights from a director of…”
Get full text

Correction: Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group’s clinical trial E3999 by Rapaport, Franck, Seier, Kenneth, Neelamraju, Yaseswini, Hassane, Duane, Baslan, Timour, Gildea, Daniel T., Haddox, Samuel, Lee, Tak, Murdock, H. Moses, Sheridan, Caroline, Thurmond, Alexis, Wang, Ling, Carroll, Martin, Cripe, Larry D., Fernandez, Hugo, Mason, Christopher E., Paietta, Elisabeth, Roboz, Gail J., Sun, Zhuoxin, Tallman, Martin S., Zhang, Yanming, Gönen, Mithat, Levine, Ross, Melnick, Ari M., Kleppe, Maria, Garrett-Bakelman, Francine E.

Get full text

Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group’s clinical trial E3999 by Rapaport, Franck, Seier, Kenneth, Neelamraju, Yaseswini, Hassane, Duane, Baslan, Timour, Gildea, Daniel T., Haddox, Samuel, Lee, Tak, Murdock, H. Moses, Sheridan, Caroline, Thurmond, Alexis, Wang, Ling, Carroll, Martin, Cripe, Larry D., Fernandez, Hugo, Mason, Christopher E., Paietta, Elisabeth, Roboz, Gail J., Sun, Zhuoxin, Tallman, Martin S., Zhang, Yanming, Gönen, Mithat, Levine, Ross, Melnick, Ari M., Kleppe, Maria, Garrett-Bakelman, Francine E.

Get full text

A New Way of Evaluating Effectiveness of URM Summer Pipeline Programs by Hill, Krystal, Raney, Catherine, Jackson, Kelli, Murdock, H Moses, Dawson, Erika, Hamilton, Roy, DeLisser, Horace, Mamtani, Mira, Aysola, Jaya

“…Many academic medical centers fund educational opportunities (pipeline programs) for students who are underrepresented in medicine (URM). However, there is a…”
Get full text

Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML by Murdock, H. Moses, Kim, Haesook T., Denlinger, Nathan, Vachhani, Pankit, Hambley, Bryan, Manning, Bryan S., Gier, Shannon, Cho, Christina, Tsai, Harrison K., McCurdy, Shannon, Ho, Vincent T., Koreth, John, Soiffer, Robert J., Ritz, Jerome, Carroll, Martin P., Vasu, Sumithira, Perales, Miguel-Angel, Wang, Eunice S., Gondek, Lukasz P., Devine, Steven, Alyea, Edwin P., Lindsley, R. Coleman, Gibson, Christopher J.

“…Older patients with acute myeloid leukemia (AML) have high relapse risk and poor survival after allogeneic hematopoietic cell transplantation (HCT). Younger…”
Get full text

Operationalizing inclusion: moving from an elusive goal to strategic action by Aysola, Jaya, Murdock, H Moses, Lett, Elle, Williams, Corey, Wade Jr, Roy, Higginbotham, Eve J

“…Abstract To mitigate the structural and institutional biases that contribute to inequities in health, we need a diverse cadre of individuals to feel included…”
Get full text

Development of a student-created internal medicine frameworks website for healthcare trainees by Murdock, H Moses, Ehrie, Jarrod, Bennett, Nadia L, Kogan, Jennifer R

“…Describe medical student perspectives on framework learning and develop a free, online, mobile-friendly framework website. Internal medicine clerkship students…”
Get more information

Adding venetoclax to fludarabine/busulfan RIC transplant for high-risk MDS and AML is feasible, safe, and active by Garcia, Jacqueline S., Kim, Haesook T., Murdock, H. Moses, Cutler, Corey S., Brock, Jennifer, Gooptu, Mahasweta, Ho, Vincent T., Koreth, John, Nikiforow, Sarah, Romee, Rizwan, Shapiro, Roman, Loschi, Fiona, Ryan, Jeremy, Fell, Geoffrey, Karp, Hannah Q., Lucas, Fabienne, Kim, Annette S., Potter, Danielle, Mashaka, Thelma, Stone, Richard M., DeAngelo, Daniel J., Letai, Anthony, Lindsley, R. Coleman, Soiffer, Robert J., Antin, Joseph H.

“…Adding the selective BCL-2 inhibitor venetoclax to reduced-intensity conditioning chemotherapy (fludarabine and busulfan [FluBu2]) may enhance antileukemic…”
Get full text

Morning report goes virtual: learner experiences in a virtual, case-based diagnostic reasoning conference by Penner, John C, Le, Stephenie, Shipley, Lindsey C, Murdock, H Moses, Minter, Daniel J, Nematollahi, Saman

“…Participation in case-based diagnostic reasoning (DR) conferences has previously been limited to those who can attend in-person. Technological advances have…”
Get more information

Allelic Complexity of KMT2A Partial Tandem Duplications in Acute Myeloid Leukemia and Myelodysplastic Syndromes by Tsai, Harrison K., Gibson, Christopher J., Murdock, H. Moses, Davineni, Phani, Harris, Marian H., Wang, Eunice S., Gondek, Lukasz P., Kim, Annette S., Nardi, Valentina, Lindsley, R. Coleman

“…KMT2A partial tandem duplication (KMT2A-PTD) is an adverse risk factor in AML and MDS, a potential therapeutic target, and an attractive marker of measurable…”
Get full text

Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML by Garcia, Jacqueline S., Kim, Haesook T., Murdock, H. Moses, Ansuinelli, Michela, Brock, Jennifer, Cutler, Corey S., Gooptu, Mahasweta, Ho, Vincent T., Koreth, John, Nikiforow, Sarah, Romee, Rizwan, Shapiro, Roman, DeAngelo, Daniel J., Stone, Richard M., Bat-Erdene, Denbaa, Ryan, Jeremy, Contreras, Manuel E., Fell, Geoffrey, Letai, Anthony, Ritz, Jerome, Lindsley, R. Coleman, Soiffer, Robert J., Antin, Joseph H.

“…•Maintenance treatment was safe, with low rates of infections and chronic GVHD, and minimal impact on T-cell immune reconstitution.•With 2-year follow-up,…”
Get full text

BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 from Target Genes by Schaefer, Eva J, Wang, Helen C, Karp, Hannah Q, Meyer, Clifford A, Cejas, Paloma, Gearhart, Micah D, Adelman, Emmalee R, Fares, Iman, Apffel, Annie, Lim, Klothilda, Xie, Yingtian, Gibson, Christopher J, Schenone, Monica, Murdock, H Moses, Wang, Eunice S, Gondek, Lukasz P, Carroll, Martin P, Vedula, Rahul S, Winer, Eric S, Garcia, Jacqueline S, Stone, Richard M, Luskin, Marlise R, Carr, Steven A, Long, Henry W, Bardwell, Vivian J, Figueroa, Maria E, Lindsley, R Coleman

“…Polycomb repressive epigenetic complexes are recurrently dysregulated in cancer. Unlike polycomb repressive complex 2 (PRC2), the role of PRC1 in oncogenesis…”
Get full text

Maintenance Therapy with Venetoclax/Azacitidine Can be Safely Given after Venetoclax/FluBu2 RIC Allogeneic Transplantation for the Treatment of High Risk MDS/AML: Results of a Phase 1 Study by Garcia, Jacqueline S., Kim, Haesook T, Brock, Jennifer, Murdock, H. Moses, Cutler, Corey S., DeAngelo, Daniel J., Gibson, Christopher J., Gooptu, Mahasweta, Ho, Vincent, Koreth, John, Luskin, Marlise R., Nikiforow, Sarah, Romee, Rizwan, Shapiro, Roman M, Stone, Richard M., Wadleigh, Martha, Winer, Eric S., Ansuinelli, Michela, Elliot, Eliza, Fell, Geoffrey, Karp, Hannah, Ryan, Jeremy, Letai, Anthony G., Lindsley, Coleman, Soiffer, Robert J, Antin, Joseph H., Loschi, Fiona, Ritz, Jerome

Get full text

Genetic Characteristics and Outcomes By Mutation Status in a Phase 3 Study of CPX-351 Versus 7+3 in Older Adults with Newly Diagnosed, High-Risk/Secondary Acute Myeloid Leukemia (AML) by Lindsley, R. Coleman, Gibson, Christopher J., Murdock, H. Moses, Stone, Richard M., Cortes, Jorge E., Uy, Geoffrey L., Lin, Tara L., Ritchie, Ellen K., Prebet, Thomas, Ryan, Robert J., Faderl, Stefan, Lancet, Jeffrey E.

“…Introduction: Molecular genetic characteristics are highly associated with clinical outcomes in AML patients treated with standard therapies. The impact of…”
Get full text

DNMT3A clonal Hematopoiesis in Older Donors Is Associated with Improved Survival in Recipients after Allogeneic Hematopoietic Cell Transplant by Gibson, Christopher J., Kim, Haesook T., Murdock, H. Moses, Hambley, Bryan, Zhao, Lin, Green, Lisa, Fleharty, Mark, Blumenstiel, Brendan, Cibulskis, Carrie, Gocke, Christopher D, Nikiforow, Sarah, DeZern, Amy E., Ho, Vincent T., Jones, Richard J., Lennon, Niall, Ritz, Jerome, Soiffer, Robert J., Gondek, Lukasz P., Lindsley, R. Coleman

“…Background: Clonal hematopoiesis (CH) is an age-related condition in which somatic mutations can be detected in the blood of healthy individuals. In the…”
Get full text

Genetic Alterations at Diagnosis Predict Outcome of AML Patients Age 60 or Older Undergoing Allogeneic Transplantation in First Remission by Murdock, H. Moses, Kim, Haesook T., Hambley, Bryan, Vachhani, Pankit, Denlinger, Nathan, Gier, Shannon H., Cho, Christina, Perales, Miguel-Angel, Koreth, John, Ho, Vincent T., Soiffer, Robert J., McCurdy, Shannon R., Carroll, Martin, Vasu, Sumithira, Wang, Eunice S., Gondek, Lukasz P., Devine, Steven, Alyea, Edwin P., Gibson, Christopher J., Lindsley, R. Coleman

“…▪ Background: Older age is associated with inferior outcomes after allogeneic hematopoietic stem cell transplantation (HSCT) for acute myeloid leukemia (AML)…”
Get full text